Atea Pharmaceuticals, Inc. (AVIR)

Atea Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	77.34	64.7	143.82	188.46	764.38	850.12
Short-Term Investments	251.97	390.03	434.28	458.25	-	-
Cash & Short-Term Investments	329.31	454.72	578.11	646.71	764.38	850.12
Cash Growth	-31.79%	-21.34%	-10.61%	-15.39%	-10.09%	3824.64%
Accounts Receivable	-	-	-	-	-	5.82
Other Receivables	-	-	5.9	-	-	-
Receivables	-	-	5.9	-	-	5.82
Prepaid Expenses	6.83	7.63	6.45	14.21	8.03	7.55
Total Current Assets	336.14	462.36	590.46	660.92	772.4	863.48
Property, Plant & Equipment	1.35	2.12	3.12	4.09	0.18	0.05
Other Long-Term Assets	5.48	0.2	1.4	1.69	0.31	0.11
Total Assets	342.96	464.67	594.97	666.71	772.89	863.63
Accounts Payable	3.52	4.46	4.25	2.55	4.53	0.06
Accrued Expenses	15.83	13.35	27.36	15.11	24.58	14.37
Current Portion of Leases	0.83	0.8	0.76	0.72	0.2	-
Current Income Taxes Payable	-	-	-	0.1	2.57	-
Current Unearned Revenue	-	-	-	-	-	301.37
Other Current Liabilities	-	-	-	-	25	-
Total Current Liabilities	20.18	18.6	32.38	18.48	56.88	315.8
Long-Term Leases	0.21	0.84	1.64	2.4	-	-
Other Long-Term Liabilities	6.8	6.36	5.76	5.26	5.93	0.04
Total Liabilities	27.18	25.8	39.78	26.14	62.82	315.83
Common Stock	0.08	0.08	0.08	0.08	0.08	0.08
Additional Paid-In Capital	793.17	802.77	750.74	701.05	653.96	612.88
Retained Earnings	-477.7	-364.22	-195.84	-59.88	56.03	-65.16
Comprehensive Income & Other	0.24	0.23	0.21	-0.68	-	-
Total Common Equity	315.78	438.87	555.19	640.57	710.08	547.8
Shareholders' Equity	315.78	438.87	555.19	640.57	710.08	547.8
Total Liabilities & Equity	342.96	464.67	594.97	666.71	772.89	863.63
Total Debt	1.05	1.64	2.4	3.12	0.2	-
Net Cash (Debt)	328.26	453.08	575.7	643.59	764.18	850.12
Net Cash Growth	-31.75%	-21.30%	-10.55%	-15.78%	-10.11%	3824.64%
Net Cash Per Share	3.95	5.38	6.90	7.73	8.66	39.37
Filing Date Shares Outstanding	78.13	85.53	84.16	83.34	83.23	82.74
Total Common Shares Outstanding	78.13	84.46	83.44	83.29	83.1	82.44
Working Capital	315.96	443.75	558.08	642.44	715.52	547.68
Book Value Per Share	4.04	5.20	6.65	7.69	8.54	6.65
Tangible Book Value	315.78	438.87	555.19	640.57	710.08	547.8
Tangible Book Value Per Share	4.04	5.20	6.65	7.69	8.54	6.65
Machinery	-	0.5	0.5	0.5	0.06	0.06
Leasehold Improvements	-	1.48	1.48	1.48	0.13	0.13

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q